SpherIngenics

SpherIngenics (SPi), headquartered in Atlanta, Georgia, is a small biotechnology company with 5 to 9 employees. The company generates between $1 million and $2 million in annual revenue. SPi specializes in developing and manufacturing patent-pending microbeads for use in cell therapy. These microbeads are constructed using alginate, a natural substance derived from algae commonly found as a food thickener. The company's technology precisely delivers cells to target areas while ensuring their viability after injection. The microbeads' ability to stay localized enhances the effectiveness of encapsulated cell therapies in regenerating damaged tissue. Furthermore, the microbeads promote the secretion of therapeutic factors, stimulating the growth and development of surrounding tissues. For more details about SpherIngenics and its innovative microbead technology, potential clients and partners can reach out to the company via email at [email protected].